Maryville NURS 615 Pharm Exam 1 Actual Exam Test Questions With Correct Verified Answers

Maryville NURS 615 Pharm Exam 1 Actual Exam Test Questions With Correct Verified Answers How does hypoalbuminemia affect the process of prescribing? - ANSWER Low albumin = more free drug (bc the drug can't bind to albumin aka protein) = increased adverse effects What is a Black Box Warning: - ANSWER is considered a contraindication to administer that drug. What is the drugs half-life? - ANSWER Half-life specifically means the amount of time it takes for an administered drug to be halfway cleared from the system. Peak of action: - ANSWER the time between drug administration and maximum concentration of drug in the blood stream. Best therapeutic effect. Duration of action: - ANSWER the time between onset of action and metabolism of drug below the minimum needed for an effect. The length of time you have the drug in your system. According to the WHO what is the first step in the prescribing process? - ANSWER The first step is to define the patient's problem The second step is to - ANSWER specify the therapeutic objective The third step is to - ANSWER choose which drug or treatment is needed. Step 4 of the WHO approach: - ANSWER Start the treatment Step 5 of the WHO approach: - ANSWER Educate the patient Step 6 of the WHO approach: - ANSWER Monitor the treatment Phase 1 of drug development: - ANSWER The drug is tested on healthy volunteers Phase 2 of drug development: - ANSWER trials with people who have the disease for which the drug is thought to be effective Phase 3 of drug development: - ANSWER Large numbers of patients in medical research centers receive the drug in phase 3. This larger sampling provides information about infrequent or rare adverse effects. The FFA will approve a new drug application if phase 3 studies are satisfactory. Phase 4 of drug development: - ANSWER This phase is voluntary and involves postmarket surveillance of the drug's therapeutic effects at the completion of phase 3. The pharmaceutical company receives reports from doctors and other health care professionals about the therapeutic results and adverse effects of the drug. Some medications, for example, have been found to be toxic and have been removed from the market after their initial release.